Abstract:Abstract Background Intrauterine exposure to a disturbed maternal glucose metabolism is associated with adverse offspring outcomes. DNA methylation is a potential mechanism underlying these associations. We examined whether maternal early-pregnancy glucose and insulin concentrations are associated with newborn DNA methylation. In a population-based prospective cohort study among 935 pregnant women, maternal plasma concentrations of non-fasting glucose and insulin were measured at a median of 13.1 weeks of gestation (95% range 9.4–17.4). DNA methylation was measured using the Infinium HumanMethylation450 BeadChip (Ilumina). We analyzed associations of maternal early-pregnancy glucose and insulin concentrations with single-CpG DNA methylation using robust linear regression models. Differentially methylated regions were analyzed using the dmrff package in R. We stratified the analyses on normal weight versus overweight or obese women. We also performed a look-up of CpGs and differently methylated regions from previous studies to be associated with maternal gestational diabetes, hyperglycemia or hyperinsulinemia, or with type 2 diabetes in adults. Results Maternal early-pregnancy glucose and insulin concentrations were not associated with DNA methylation at single CpGs nor with differentially methylated regions in the total group. In analyses stratified on maternal BMI, maternal early-pregnancy glucose concentrations were associated with DNA methylation at one CpG (cg03617420, XKR6 ) among normal weight women and at another (cg12081946, IL17D ) among overweight or obese women. No stratum-specific associations were found for maternal early-pregnancy insulin concentrations. The two CpGs were not associated with birth weight or childhood glycemic measures ( p values > 0.1). Maternal early-pregnancy insulin concentrations were associated with one CpG known to be related to adult type 2 diabetes. Enrichment among nominally significant findings in our maternal early-pregnancy glucose concentrations was found for CpGs identified in a previous study on adult type 2 diabetes. Conclusions Maternal early-pregnancy glucose concentrations, but not insulin concentrations, were associated with DNA methylation at one CpG each in the subgroups of normal weight and of overweight or obese women. No associations were present in the full group. The role of these CpGs in mechanisms underlying offspring health outcomes needs further study. Future studies should replicate our results in larger samples with early-pregnancy information on maternal fasting glucose metabolism.

Prenatal Gestational Diabetes Mellitus Exposure and Accelerated Offspring DNA Methylation Age in Early Childhood.

Genome-wide DNA Methylation Profiling in Infants Born to Gestational Diabetes Mellitus

Increased Methylation at Differentially Methylated Region of GNASin Infants Born to Gestational Diabetes

The Association of Gestational Diabetes Mellitus with Fetal Birth Weight.

Placental Delta-Like 1 Gene DNA Methylation Levels Are Related to Mothers’ Blood Glucose Concentration

Abstract P073: A Novel Epigenetic Link Between Gestational Diabetes Mellitus and Macrosomia

Methylation Levels at Igf2 and Gnas Dmrs in Infants Born to Preeclamptic Pregnancies

Altered DNA methylation in neonates born large-for-gestational-age is associated with cardiometabolic risk in children.

Offspring Risk of Obesity in Childhood, Adolescence and Adulthood in Relation to Gestational Diabetes Mellitus: a Sex-Specific Association

Maternal glycemia in pregnancy is longitudinally associated with blood DNAm variation at the FSD1L gene from birth to 5 years of age

Intrauterine Hyperglycemia Exposure Results in Intergenerational Inheritance Via DNA Methylation Reprogramming on F1 PGCs

Associations of maternal early-pregnancy blood glucose and insulin concentrations with DNA methylation in newborns

Association of DNA Methylation with Infant Birth Weight in Women with Gestational Diabetes

Gestational diabetes and offspring’s growth from birth to 6 years old

Maternal gestational diabetes and childhood adiposity risk from 6 to 8 years of age

Insulin Therapy of Gestational Diabetes Does Not Fully Protect Offspring from Diet-Induced Metabolic Disorders.

Deciphering DNA Methylation in Gestational Diabetes Mellitus: Epigenetic Regulation and Potential Clinical Applications

Genome-Wide Placental Gene Methylations in Gestational Diabetes Mellitus, Fetal Growth and Metabolic Health Biomarkers in Cord Blood

Epigenetic marks associated with gestational diabetes mellitus across two time points during pregnancy

Maternal Gestational Diabetes and Different Indicators of Childhood Obesity: a Large Study

The association between dietary, physical activity and the DNA methylation of PPARGC1A, HLA-DQA1 and ADCY3 in pregnant women with gestational diabetes mellitus: a nest case-control study